Audio By Carbonatix
Ghanaian forward Antoine Semenyo has chosen Manchester City over rivals Manchester United, Liverpool and Chelsea ahead of a possible January move.
The 25-year-old has been one of the most sought-after players after a sizzling start to the English Premier League with eight goals and three assists – the third top scorer in England’s top-flight.
The Bournemouth man has a £65m release clause available until Jan 10.
After discussions with defending champions Liverpool, Chelsea and Manchester United, Semenyo has favoured a move to the Etihad Stadium.
It is understood City and Bournemouth will hold direct talks to reach agreement for the attacker.
Bournemouth boss Andoni Iraola said: "Antoine Semenyo right now is with us.
“He's playing very well. My concern is that it doesn't affect him. He's played very well, he's committed to the team and I hope we can keep him. There are things happening out of our control.”
Latest Stories
-
Shell to sell its Nigeria gas business to Vaaris Energy
48 minutes -
Judge extends White House access for CNN, MS NOW, Politico amid legal fight
56 minutes -
EU expands migration cooperation with eastern Libya through new funding
1 hour -
Actress Selma Blair faces charges for kicking nurse and officer after plane incident
1 hour -
Private political loyalties deserve scrutiny too in EC appointments – Osae-Kwapong
1 hour -
EC safeguards must check partisan bias among commissioners – Osae-Kwapong
2 hours -
Oil prices climb as traders weigh Saudi supply risk, Russian diesel flow
2 hours -
Zimbabwean author denies using AI to write award-winning story
2 hours -
Bank of America hit with $1.2bn fine for money laundering failings
2 hours -
Robot seized by German police after allegedly groping teenage girl
2 hours -
Subject EC appointment to ‘Akufo-Addo test’ – Kwapong
3 hours -
English football’s independent regulator would quit over Man City interference
3 hours -
Anthropic seeks rehearing of case over Pentagon’s security risk branding
3 hours -
Torrential rains in Libya’s Tripoli kill two
3 hours -
Guinea-Bissau says it has not approved hepatitis B vaccine trial in newborns
3 hours